Stockscreener 앱 받기
219.16
0.05%
0.12
Abbvie Inc 주식(ABBV)의 최신 뉴스
Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now - The Motley Fool
Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer - Seeking Alpha
Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating - Insider Monkey
Reversal indicators forming on AbbVie Inc. stockJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Should AbbVie's (ABBV) Dividend Hike and Lower Guidance Prompt a Closer Look at Earnings Stability? - simplywall.st
UBS Adjusts Price Target on AbbVie to $220 From $195, Maintains Neutral Rating - MarketScreener
Is AbbVie Inc. stock undervalued vs historical averagesRate Cut & AI Optimized Trading Strategy Guides - newser.com
Harvest Portfolios Group Inc. Has $55.10 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Shaping the future of science, together - AbbVie
The Top 5 Analyst Questions From AbbVie’s Q3 Earnings Call - The Globe and Mail
Will AbbVie Inc. stock attract more institutional investorsWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - newser.com
How AbbVie Inc. (4AB) stock benefits from digital adoptionJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Why AbbVie Inc. stock is trending among retail traders2025 Support & Resistance & Long Hold Capital Preservation Tips - fcp.pa.gov.br
Can AbbVie Inc. stock attract analyst upgradesWall Street Watch & Capital Efficient Trade Techniques - newser.com
Analyzing AbbVie Inc. with risk reward ratio chartsEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
How AbbVie Inc. (4AB) stock performs in volatility spikes2025 Big Picture & Short-Term High Return Strategies - newser.com
How AbbVie Inc. stock performs in rising dollar environmentQuarterly Earnings Summary & High Yield Equity Trading Tips - newser.com
Is AbbVie Inc. stock resilient to inflationJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com
Is AbbVie Inc. reversing from oversold territoryWeekly Loss Report & Verified Momentum Watchlists - newser.com
Is AbbVie Inc. (4AB) stock undervalued after correctionExit Point & Momentum Based Trading Ideas - newser.com
Market Rankings: Can AbbVie Inc. stock retain market dominanceGold Moves & Fast Moving Trade Plans - fcp.pa.gov.br
Can momentum traders help lift AbbVie Inc.July 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Jim Cramer Says “I Found the AbbVie Call Particularly Jarring” - MSN
Will AbbVie Inc. stock reach all time highs in 2025July 2025 Chart Watch & High Conviction Buy Zone Picks - fcp.pa.gov.br
AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here? - Barchart.com
Ironwood wins new FDA nod for AbbVie-partnered bowel drug - Seeking Alpha
ABBV Receives New Price Target and Overweight Rating from Piper Sandler | ABBV Stock News - GuruFocus
AbbVie's (ABBV) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - Yahoo Finance
FY2025 EPS Estimates for AbbVie Reduced by Cantor Fitzgerald - MarketBeat
First Horizon Advisors Inc. Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Genus Capital Management Inc. - MarketBeat
Can AbbVie Inc. stock retain market dominanceJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
AbbVie Inc. $ABBV Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
AbbVie Inc. $ABBV is Commonwealth Retirement Investments LLC's 4th Largest Position - MarketBeat
Jacobson & Schmitt Advisors LLC Takes $377,000 Position in AbbVie Inc. $ABBV - MarketBeat
Claro Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
Corps Capital Advisors LLC Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Why AbbVie Inc. (4AB) stock stays on top picksMarket Trend Review & Growth Focused Stock Reports - newser.com
Using R and stats models for AbbVie Inc. forecastingBond Market & AI Powered Market Trend Analysis - newser.com
How to recover losses in AbbVie Inc. stockMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is AbbVie Inc. stock a buy on dipsOil Prices & Risk Managed Investment Signals - newser.com
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight - GuruFocus
AbbVie (NYSE:ABBV) Shares Up 1.9% After Analyst Upgrade - MarketBeat
AbbVie Inc. SEC 10-Q Report - TradingView
AbbVie (ABBV) Receives a Buy from BMO Capital - The Globe and Mail
Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain ShiftsGlobal Forecast to 2034 - Yahoo Finance
Bernstein raises AbbVie stock price target to $225 on long-term growth - Investing.com Nigeria
Bernstein Adjusts Price Target on AbbVie to $225 From $203, Maintains Market Perform Rating - MarketScreener
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More - Yahoo Finance
AbbVie (NYSE:ABBV) Downgraded to "Hold" Rating by DZ Bank - MarketBeat
AbbVie Inc. (NYSE:ABBV) Q3 2025 Earnings Call Transcript - Insider Monkey
Here Are Tuesday's Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More - 24/7 Wall St.
Tufton Capital Management Has $10.25 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Magnolia Capital Advisors LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Code Waechter LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
EPG Wealth Management LLC Sells 2,439 Shares of AbbVie Inc. $ABBV - MarketBeat
0.21%
0.58%
자본화:
|
볼륨(24시간):